Total Payments
$5,658
2024 Payments
$1,080
Companies
16
Transactions
113
Medicare Patients
9,844
Medicare Billing
$9.3M
Payment Breakdown by Category
Food & Beverage$4,185 (74.0%)
Other$1,434 (25.3%)
Gifts$38.80 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,185 | 108 | 74.0% |
| Grant | $1,200 | 1 | 21.2% |
| Entertainment | $233.85 | 2 | 4.1% |
| Gift | $38.80 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $2,405 | 31 | $0 (2024) |
| Genentech USA, Inc. | $1,401 | 43 | $0 (2024) |
| Allergan, Inc. | $455.14 | 8 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $319.67 | 7 | $0 (2024) |
| OPTOS, INC. | $233.85 | 2 | $0 (2019) |
| Alimera Sciences, Inc. | $150.94 | 4 | $0 (2024) |
| ABBVIE INC. | $125.92 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $120.73 | 1 | $0 (2019) |
| Alcon Laboratories Inc | $103.32 | 1 | $0 (2018) |
| Genentech, Inc. | $91.60 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,080 | 26 | Regeneron Healthcare Solutions, Inc. ($467.54) |
| 2023 | $1,772 | 19 | Regeneron Healthcare Solutions, Inc. ($1,494) |
| 2022 | $470.86 | 11 | Genentech USA, Inc. ($381.82) |
| 2021 | $415.52 | 13 | Allergan, Inc. ($199.90) |
| 2020 | $213.09 | 5 | Allergan, Inc. ($126.03) |
| 2019 | $498.38 | 10 | Genentech USA, Inc. ($186.61) |
| 2018 | $644.08 | 14 | Genentech USA, Inc. ($286.22) |
| 2017 | $563.54 | 15 | Optos, Inc. ($191.98) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/04/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: Ophthalmology | ||||||
| 10/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $132.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $30.40 | General |
| Category: Ophthalmology | ||||||
| 06/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $139.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: Ophthalmology | ||||||
| 05/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: EYE CARE | ||||||
| 04/25/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $114.45 | General |
| Category: Ophthalmology | ||||||
| 04/24/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $96.98 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: Ophthalmology | ||||||
| 03/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $36.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,684 | 23,297 | $5.9M | $2.4M |
| 2022 | 15 | 2,425 | 11,393 | $6.3M | $2.4M |
| 2021 | 13 | 2,326 | 8,873 | $6.4M | $2.4M |
| 2020 | 15 | 2,409 | 8,751 | $5.6M | $2.1M |
Total Patients
9,844
Total Services
52,314
Medicare Billing
$9.3M
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 197 | 1,850 | $2.3M | $1.3M | 55.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 77 | 15,180 | $632,551 | $442,002 | 69.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 292 | 1,456 | $1.6M | $140,078 | 9.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 35 | 620 | $358,400 | $112,532 | 31.4% |
| J3590 | Unclassified biologics | Office | 2023 | 20 | 50 | $150,000 | $105,987 | 70.7% |
| 92134 | Imaging of retina | Office | 2023 | 600 | 2,110 | $422,000 | $70,258 | 16.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 459 | 536 | $85,760 | $54,571 | 63.6% |
| J3490 | Unclassified drugs | Office | 2023 | 14 | 29 | $76,500 | $49,802 | 65.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 267 | 504 | $63,000 | $37,807 | 60.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 11 | 189 | $40,635 | $29,776 | 73.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 227 | 227 | $63,560 | $28,223 | 44.4% |
| 92250 | Photography of the retina | Office | 2023 | 353 | 365 | $73,000 | $11,659 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 75 | $13,500 | $7,848 | 58.1% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 16 | 56 | $7,000 | $4,085 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 50 | $7,500 | $3,859 | 51.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 212 | 2,068 | $2.6M | $1.5M | 57.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 59 | 1,061 | $614,900 | $238,119 | 38.7% |
| J3590 | Unclassified biologics | Office | 2022 | 48 | 117 | $292,500 | $214,442 | 73.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 284 | 1,486 | $2.0M | $142,625 | 7.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 38 | 2,820 | $117,509 | $84,153 | 71.6% |
| 92134 | Imaging of retina | Office | 2022 | 661 | 2,229 | $445,800 | $75,569 | 17.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 339 | 378 | $60,480 | $36,510 | 60.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 260 | 485 | $60,625 | $36,003 | 59.4% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 14 | 196 | $42,140 | $30,937 | 73.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 211 | 211 | $59,080 | $28,256 | 47.8% |
About Dr. Thomas Hanscom, MD
Dr. Thomas Hanscom, MD is a Ophthalmology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063476448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Hanscom, MD has received a total of $5,658 in payments from pharmaceutical and medical device companies, with $1,080 received in 2024. These payments were reported across 113 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,185).
As a Medicare-enrolled provider, Hanscom has provided services to 9,844 Medicare beneficiaries, totaling 52,314 services with total Medicare billing of $9.3M. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Santa Monica, CA
- Active Since 04/13/2006
- Last Updated 05/28/2014
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1063476448
Products in Payments
- EYLEA (Biological) $1,722
- Lucentis (Biological) $940.99
- EYLEA HD (Biological) $452.11
- Vabysmo (Drug) $349.87
- Syfovre (Drug) $271.07
- EYLEA AFLIBERCEPT INJECTION (Biological) $230.89
- OZURDEX (Drug) $218.51
- California (Device) $191.98
- VABYSMO (Drug) $175.66
- ReSTOR (Device) $103.32
- YUTIQ (Drug) $96.98
- P200DTx (Device) $41.87
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $40.93
- None Specified (Medical Supply) $38.80
- Iluvien (Drug) $37.70
- Bromsite (Drug) $24.97
- PROLENSA (Drug) $21.93
- ILUVIEN (Drug) $16.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Santa Monica
Dr. Kenneth Hoffer, Md, MD
Ophthalmology — Payments: $323,358
Ophthalmology $323,358
Dr. William Christian, M.d, M.D
Ophthalmology — Payments: $34,632
Ophthalmology $34,632
Gavin Bahadur, M.d, M.D
Ophthalmology — Payments: $13,427
Ophthalmology $13,427
Howard Krauss, M.d, M.D
Ophthalmology — Payments: $8,143
Ophthalmology $8,143
Sadiqa Stelzner, Md, MD
Ophthalmology — Payments: $8,050
Ophthalmology $8,050
Dr. Erfan Nadji, M.d, M.D
Ophthalmology — Payments: $5,651
Ophthalmology $5,651